Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 61451-61500 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06050369
Objective Characterizatoion of Repetitive Behaviors
NA
Recruiting
50 participants
Started: Dec 28, 2023 · Completed: Dec 27, 2027
3 conditions
1 sponsor
3 locations
NCT06197178
A Study of LCAR-G08 in Subjects With Advanced Gastrointestinal Tumors Expressing Guanylyl Cyclase C (GCC)
PHASE1
Recruiting
42 participants
Started: Dec 28, 2023 · Completed: Mar 31, 2028
1 condition
2 sponsors
2 locations
NCT06002607
Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections
N/A
Recruiting
50 participants
Started: Dec 28, 2023 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT06716983
Multimodal Investigation of Cortico-Basal Ganglia-Thalamo-Cortical Network Dynamics in Dystonic Patients with Deep Brain Stimulation
N/A
Recruiting
15 participants
Started: Dec 28, 2023 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05441280
Pimavanserin for Insomnia in Veterans With PTSD
PHASE2
Recruiting
60 participants
Started: Dec 28, 2023 · Completed: Jul 12, 2027
2 conditions
1 sponsor
1 location
NCT06168851
Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)
PHASE2
Recruiting
20 participants
Started: Dec 28, 2023 · Completed: Dec 31, 2025
2 conditions
3 sponsors
1 location
NCT06148506
A Prospective NIS to Evaluate the Clinical Outcomes of Risarg® (Ribociclib) Combined With Endocrine Therapy or Chemotherapy in Patients With HR+HER2 - aBC in Routine Clinical Practice in the Russia
N/A
Recruiting
376 participants
Started: Dec 28, 2023 · Completed: Jun 30, 2027
1 condition
1 sponsor
21 locations
NCT06279741
Safety and Efficacy of MSC-EVs in the Prevention of BPD in Extremely Preterm Infants
PHASE1/PHASE2
Recruiting
265 participants
Started: Dec 28, 2023 · Completed: Dec 31, 2029
1 condition
1 sponsor
8 locations
NCT06129240
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
N/A
Recruiting
60 participants
Started: Dec 28, 2023 · Completed: Oct 31, 2026
2 conditions
1 sponsor
23 locations
NCT06174363
Analgesic Efficacy of Maxigesic in Breast Cancer Surgery
NA
Recruiting
84 participants
Started: Dec 28, 2023 · Completed: Dec 26, 2025
1 condition
1 sponsor
1 location
NCT06096337
Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
NA
Active, not recruiting
484 participants
Started: Dec 28, 2023 · Completed: Feb 3, 2028
1 condition
1 sponsor
64 locations
NCT06145282
Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function
PHASE1/PHASE2
Active, not recruiting
6 participants
Started: Dec 28, 2023 · Completed: Nov 26, 2027
1 condition
1 sponsor
1 location
NCT05934526
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
PHASE3
Active, not recruiting
390 participants
Started: Dec 28, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
189 locations
NCT06217900
a PROspective Case Control Study to Develop and Validate a Blood Test FOr mUlti-caNcers Early Detection(PROFOUND)
N/A
Recruiting
16,666 participants
Started: Dec 28, 2023 · Completed: Mar 31, 2027
1 condition
2 sponsors
2 locations
NCT05905328
Study of CTO1681 for the Prevention and Treatment of CRS in DLBCL Patients Receiving CAR T-Cell Therapy
PHASE1/PHASE2
Recruiting
54 participants
Started: Dec 28, 2023 · Completed: Jun 30, 2027
1 condition
1 sponsor
6 locations
NCT05910177
Neoadjuvant Treatment of Neuroendocrine Cervix Carcinomar With Camrelizumab Combined With Etoposide and Cisplatin
PHASE2
Recruiting
30 participants
Started: Dec 28, 2023 · Completed: Aug 31, 2026
2 conditions
1 sponsor
1 location
NCT06176222
Combined Use of Naldebain® ER Injection and Precedex® After VATS
PHASE4
Not yet recruiting
70 participants
Started: Dec 28, 2023 · Completed: Mar 31, 2026
3 conditions
1 sponsor
1 location
NCT06260397
Serratus Anterior Plane Block and Costotransverse Block for Analgesia Following Modified Radical Mastectomy Surgeries
NA
Recruiting
90 participants
Started: Dec 28, 2023 · Completed: Mar 30, 2025
1 condition
1 sponsor
1 location
NCT05966025
Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD)
PHASE2
Not yet recruiting
60 participants
Started: Dec 28, 2023 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT06282341
Fatigue and Recovery: a Comparison Between Trail and Marathon
NA
Recruiting
90 participants
Started: Dec 28, 2023 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT06115733
Study of Fuquinitinib Combined With Capecitabine First-line Maintenance in the Treatment of Metastatic Colorectal Cancer
NA
Not yet recruiting
56 participants
Started: Dec 28, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
0 locations
NCT06149286
A Trial to Learn if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
PHASE3
Recruiting
470 participants
Started: Dec 28, 2023 · Completed: Jan 23, 2029
2 conditions
1 sponsor
158 locations
NCT06247085
A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Age With Classical Homocystinuria (HCU) Due to Cystathionine Beta Synthase Deficiency Receiving Standard of Care Treatment
PHASE3
Active, not recruiting
70 participants
Started: Dec 28, 2023 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT06234397
Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors
PHASE1
Recruiting
245 participants
Started: Dec 28, 2023 · Completed: Jan 31, 2028
1 condition
2 sponsors
8 locations
NCT06200220
Patients Treated in Real Life With VEnetoclax for WAldenström Macroglobulinemia
N/A
Recruiting
45 participants
Started: Dec 28, 2023 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT06174532
Virtual Surgical Planning in Mandibular Segmental Resection
NA
Recruiting
30 participants
Started: Dec 27, 2023 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT06141486
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
PHASE3
Recruiting
900 participants
Started: Dec 27, 2023 · Completed: Mar 24, 2028
1 condition
1 sponsor
321 locations
NCT06913998
The Prevalence and Impacts of Nudix Hydrolase 15 (NUDT15) Gene Variants in Taiwanese Inflammatory Bowel Disease
N/A
Recruiting
65 participants
Started: Dec 27, 2023 · Completed: Nov 30, 2026
3 conditions
1 sponsor
1 location
NCT06693973
An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
EARLY_PHASE1
Recruiting
13 participants
Started: Dec 27, 2023 · Completed: Jan 13, 2026
1 condition
2 sponsors
1 location
NCT06223880
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
PHASE4
Recruiting
350 participants
Started: Dec 27, 2023 · Completed: Mar 31, 2026
1 condition
1 sponsor
40 locations
NCT06969742
Development and Application of Intervention Program to Improve Mental Health and Quality of Life of Solid Tumor Survivors and Caregivers
NA
Recruiting
120 participants
Started: Dec 27, 2023 · Completed: Dec 31, 2028
1 condition
3 sponsors
3 locations
NCT06010329
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
PHASE2
Recruiting
66 participants
Started: Dec 27, 2023 · Completed: Apr 30, 2026
1 condition
1 sponsor
9 locations
NCT06072807
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
PHASE4
Recruiting
20 participants
Started: Dec 27, 2023 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT06173505
Study of Vudalimab or Pembrolizumab in Combination With Chemotherapy as First-line Treatment in Patients With Advanced NSCLC
PHASE1/PHASE2
Recruiting
168 participants
Started: Dec 27, 2023 · Completed: Oct 31, 2027
1 condition
1 sponsor
43 locations
NCT06201741
A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled ZT-111 in Patients With Metastatic Prostate Cancer
NA
Recruiting
10 participants
Started: Dec 27, 2023 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT06182527
Relevance of Reactive Hypoglycemia During an OGTT in Everyday Life Using Continuous Glucose Measurement
NA
Recruiting
20 participants
Started: Dec 27, 2023 · Completed: Jul 31, 2025
1 condition
1 sponsor
1 location
NCT06158490
A Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic Dermatitis
PHASE2
Enrolling by invitation
120 participants
Started: Dec 27, 2023 · Completed: Oct 10, 2026
1 condition
1 sponsor
1 location
NCT06220552
The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma
PHASE2
Recruiting
20 participants
Started: Dec 27, 2023 · Completed: Dec 30, 2027
1 condition
1 sponsor
1 location
NCT06394076
A Study to Evaluate the Safety and Effectiveness of Injectable Gel for Correction of Infraorbital Hollowing in Chinese Population
NA
Recruiting
172 participants
Started: Dec 27, 2023 · Completed: Apr 30, 2025
1 condition
1 sponsor
1 location
NCT05691465
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
PHASE2
Recruiting
30 participants
Started: Dec 27, 2023 · Completed: Nov 1, 2025
4 conditions
1 sponsor
13 locations
NCT05758896
Study of APX-115 in Contrast Induced Acute Kidney Injury in Subjects Undergoing PCI
PHASE2
Recruiting
280 participants
Started: Dec 27, 2023 · Completed: Dec 31, 2024
1 condition
1 sponsor
14 locations
NCT06201117
Effects of Preparatory Information on Anxiety and Treatment Adherence in Heart Surgery Patients
NA
Recruiting
48 participants
Started: Dec 27, 2023 · Completed: Sep 30, 2024
1 condition
1 sponsor
1 location
NCT06874530
Efficacy of Isatuximab-based Regimens in Relapsed/Refractory Multiple Myeloma With 1q21+
N/A
Recruiting
30 participants
Started: Dec 27, 2023 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT06059638
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NA
Recruiting
500 participants
Started: Dec 27, 2023 · Completed: Aug 31, 2029
3 conditions
2 sponsors
78 locations
NCT06087627
A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical Routine
N/A
Recruiting
150 participants
Started: Dec 27, 2023 · Completed: Dec 28, 2026
1 condition
1 sponsor
11 locations
NCT06142552
Phase 3 Clinical Project of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein
PHASE3
Recruiting
120 participants
Started: Dec 27, 2023 · Completed: Sep 1, 2026
1 condition
1 sponsor
28 locations
NCT06569589
Tissue Sodium Quantification in Patients With Primary Aldosteronism: See Sodium to Treat
N/A
Recruiting
80 participants
Started: Dec 27, 2023 · Completed: Aug 31, 2026
3 conditions
4 sponsors
4 locations
NCT06201000
Effect of Genetic Polymorphisms on the Clinical Response to SGLT2 Inhibitors in Heart Failure Patients
N/A
Recruiting
282 participants
Started: Dec 27, 2023 · Completed: Sep 1, 2024
2 conditions
4 sponsors
1 location
NCT06182800
Adebrelimab Combined With Bevacizumab and Docetaxel for Advanced Non-Squamous Non-small Cell Lung Cancer After Progression on First-line Immunotherapy
PHASE2
Not yet recruiting
35 participants
Started: Dec 27, 2023 · Completed: Dec 30, 2025
1 condition
1 sponsor
0 locations
NCT06008691
A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice
N/A
Recruiting
1,500 participants
Started: Dec 27, 2023 · Completed: Oct 31, 2038
1 condition
2 sponsors
61 locations
Previous
1
More pages
1227
1228
1229
1230
1231
1232
1233
More pages
2369
Next